Liu S - Search Results

1

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.

Gonzalez-Angulo AM, Timms KM, Liu S, Chen H, Litton JK, Potter J, Lanchbury JS, Stemke-Hale K, Hennessy BT, Arun BK, Hortobagyi GN, Do KA, Mills GB, Meric-Bernstam F. Gonzalez-Angulo AM, et al. Among authors: liu s. Clin Cancer Res. 2011 Mar 1;17(5):1082-9. doi: 10.1158/1078-0432.CCR-10-2560. Epub 2011 Jan 13. Clin Cancer Res. 2011. PMID: 21233401 Free PMC article.

2

Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor.

Hasegawa Y, Erickson JR, Goddard GJ, Yu S, Liu S, Cheng KW, Eder A, Bandoh K, Aoki J, Jarosz R, Schrier AD, Lynch KR, Mills GB, Fang X. Hasegawa Y, et al. Among authors: liu s. J Biol Chem. 2003 Apr 4;278(14):11962-9. doi: 10.1074/jbc.M209168200. Epub 2003 Jan 27. J Biol Chem. 2003. PMID: 12554733 Free article.

3

ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers.

Luo RZ, Fang X, Marquez R, Liu SY, Mills GB, Liao WS, Yu Y, Bast RC. Luo RZ, et al. Among authors: liu sy. Oncogene. 2003 May 15;22(19):2897-909. doi: 10.1038/sj.onc.1206380. Oncogene. 2003. PMID: 12771940

4

Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells.

Fang X, Yu S, Bast RC, Liu S, Xu HJ, Hu SX, LaPushin R, Claret FX, Aggarwal BB, Lu Y, Mills GB. Fang X, et al. Among authors: liu s. J Biol Chem. 2004 Mar 5;279(10):9653-61. doi: 10.1074/jbc.M306662200. Epub 2003 Dec 11. J Biol Chem. 2004. PMID: 14670967 Free article.

5

Lysophosphatidic acid production and action: validated targets in cancer?

Umezu-Goto M, Tanyi J, Lahad J, Liu S, Yu S, Lapushin R, Hasegawa Y, Lu Y, Trost R, Bevers T, Jonasch E, Aldape K, Liu J, James RD, Ferguson CG, Xu Y, Prestwich GD, Mills GB. Umezu-Goto M, et al. Among authors: liu j, liu s. J Cell Biochem. 2004 Aug 15;92(6):1115-40. doi: 10.1002/jcb.20113. J Cell Biochem. 2004. PMID: 15258897 Review.

6

Glycogen synthase kinase 3beta is a negative regulator of growth factor-induced activation of the c-Jun N-terminal kinase.

Liu S, Yu S, Hasegawa Y, Lapushin R, Xu HJ, Woodgett JR, Mills GB, Fang X. Liu S, et al. J Biol Chem. 2004 Dec 3;279(49):51075-81. doi: 10.1074/jbc.M408607200. Epub 2004 Oct 1. J Biol Chem. 2004. PMID: 15466414 Free PMC article.

7

Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.

Lee Z, Swaby RF, Liang Y, Yu S, Liu S, Lu KH, Bast RC Jr, Mills GB, Fang X. Lee Z, et al. Among authors: liu s. Cancer Res. 2006 Mar 1;66(5):2740-8. doi: 10.1158/0008-5472.CAN-05-2947. Cancer Res. 2006. PMID: 16510595

8

Of spiders and crabs: the emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer.

Murph M, Tanaka T, Liu S, Mills GB. Murph M, et al. Among authors: liu s. Clin Cancer Res. 2006 Nov 15;12(22):6598-602. doi: 10.1158/1078-0432.CCR-06-1721. Clin Cancer Res. 2006. PMID: 17121877 Review.

9

Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.

Estrella VC, Eder AM, Liu S, Pustilnik TB, Tabassam FH, Claret FX, Gallick GE, Mills GB, Wiener JR. Estrella VC, et al. Among authors: liu s. Int J Oncol. 2007 Aug;31(2):441-9. Int J Oncol. 2007. PMID: 17611702

10

Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.

Murph M, Tanaka T, Pang J, Felix E, Liu S, Trost R, Godwin AK, Newman R, Mills G. Murph M, et al. Among authors: liu s. Methods Enzymol. 2007;433:1-25. doi: 10.1016/S0076-6879(07)33001-2. Methods Enzymol. 2007. PMID: 17954226

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71,756 results

Search Page